Enbrel Liquid Immunogenicity Protocol
NCT00249041 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 447
Last updated 2010-07-30
Summary
The purpose of this study is to assess the antibody formation to Enbrel liquid in subjects with Rheumatoid Arthritis
Conditions
Interventions
- DRUG
-
50 mg Etanercept
50 mg Etanercept liquid injected SC once weekly using prefilled syringes
- DRUG
-
Enbrel liquid
50 mg Etanercept liquid injected SC once weekly using prefilled syringes
Sponsors & Collaborators
-
Immunex Corporation
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
MD · Amgen
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2006-12-31
- Completion
- 2007-03-31
More Related Trials
-
Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
NCT00244556 ·Status: COMPLETED ·Phase: PHASE4
-
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
NCT01313208 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
NCT01901185 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)
NCT00099554 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Safety of Enbrel (Etanercept)
NCT00683384 ·Status: COMPLETED
-
Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children
NCT00484809 ·Status: COMPLETED
-
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
NCT02486302 ·Status: COMPLETED
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
NCT04079374 ·Status: UNKNOWN ·Phase: PHASE3
-
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
NCT04428424 ·Status: COMPLETED
-
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
NCT01188655 ·Status: COMPLETED
-
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study
NCT00522184 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
NCT00459706 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria
NCT01877239 ·Status: COMPLETED
-
Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects
NCT00706797 ·Status: TERMINATED ·Phase: PHASE4
-
Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
NCT00503503 ·Status: COMPLETED
-
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
NCT00078793 ·Status: COMPLETED
-
Etanercept (Enbrel) in Ankylosing Spondylitis
NCT01289743 ·Status: UNKNOWN ·Phase: PHASE2
-
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
NCT01981473 ·Status: COMPLETED
-
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
NCT00116727 ·Status: COMPLETED
-
Prospective Evaluation of the Radiographic Efficacy of Enbrel
NCT01623752 ·Status: COMPLETED
-
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012
NCT00356590 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
NCT01411215 ·Status: TERMINATED
-
Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis
NCT02986139 ·Status: COMPLETED ·Phase: PHASE3